Drug Search Results
More Filters [+]

Eugenol

Alternative Names: eugenol
Latest Update: 2024-11-13
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Voltage-Gated Sodium Channel Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Argentina | Australia | Austria | Chile | China | Colombia | Cyprus | France | Germany | Greece | Hong Kong | India | Indonesia | Ireland | Italy | Lithuania | Malaysia | Morocco | Netherlands | Pakistan | Philippines | Slovenia | Spain | Sweden | Taiwan | Thailand | United Arab Emirates | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Colgate Palmolive
Company Location: NEW YORK NY 10022
Company CEO: Noel R. Wallace
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Eugenol

Countries in Clinic: Germany

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Dental Plaque

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CRO-2022-10-PG-MER-MW-JG

P3

Completed

Dental Plaque

2024-03-06

38%

Recent News Events